Balko, Justin M.
Vanderbilt University Medical Center,
United States
2025 Rank: 49626
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1480 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 49626 | 53345 |
| Total Cites | 3270 | 3426 |
| H-index | 25 | 27 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 63 | 65 |
| Number of Single+First+Last Authored Papers | 54 | 54 |
| Total Cites to Single+First+Last Authored Papers | 771 | 796 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2697 | 2789 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.23 |
| Self-Citation Percentage |
4.55%
|
|
Balko, Justin M.
Vanderbilt University Medical Center,
United States
2024 Rank: 43198
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1389 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43198 | 47261 |
| Total Cites | 3166 | 3346 |
| H-index | 27 | 28 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 75 | 76 |
| Number of Single+First+Last Authored Papers | 51 | 51 |
| Total Cites to Single+First+Last Authored Papers | 706 | 747 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2638 | 2727 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.23 |
| Self-Citation Percentage |
5.38%
|
|
Balko, Justin M.
Vanderbilt University Medical Center,
United States
2023 Rank: 44646
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1579 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 44646 | 48145 |
| Total Cites | 3103 | 3286 |
| H-index | 26 | 28 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 98 | 103 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 536 | 564 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 2522 | 2614 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.26 |
| Self-Citation Percentage |
5.57%
|
|
Balko, Justin M.
Vanderbilt University Medical Center,
United States
2022 Rank: 50859
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1938 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50859 | 55214 |
| Total Cites | 2792 | 3069 |
| H-index | 25 | 27 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 100 | 102 |
| Number of Single+First+Last Authored Papers | 41 | 41 |
| Total Cites to Single+First+Last Authored Papers | 422 | 448 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2317 | 2463 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
9.03%
|
|
Balko, Justin M.
Vanderbilt University Medical Center,
United States
2021 Rank: 62983
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2271 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 62983 | 67872 |
| Total Cites | 3681 | 4038 |
| H-index | 28 | 30 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 142 | 153 |
| Number of Single+First+Last Authored Papers | 36 | 36 |
| Total Cites to Single+First+Last Authored Papers | 572 | 611 |
| Composite Score | 2 | 3 |
| Number of Distinct Citing Papers | 3108 | 3299 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.22 |
| Self-Citation Percentage |
8.84%
|
|
Balko, Justin M.
Vanderbilt University Medical Center,
United States
2020 Rank: 81273
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2847 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81273 | 86580 |
| Total Cites | 1967 | 2183 |
| H-index | 20 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 135 | 144 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 346 | 370 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1708 | 1841 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.19 |
| Self-Citation Percentage |
9.89%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.